Insider Buying: AdaptHealth (NASDAQ:AHCO) Major Shareholder Acquires $5,223,326.71 in Stock

AdaptHealth Corp. (NASDAQ:AHCO) major shareholder Richard Cashin, Jr. acquired 536,827 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The shares were acquired at an average cost of $9.73 per share, with a total value of $5,223,326.71. Following the purchase, the insider directly owned 15,175,535 shares of the company’s stock, valued at $147,657,955.55. This trade represents a 3.67% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

AdaptHealth Price Performance

Shares of NASDAQ AHCO opened at $10.60 on Friday. The firm has a market capitalization of $1.44 billion, a P/E ratio of -19.27, a P/E/G ratio of 1.22 and a beta of 1.76. The company has a quick ratio of 0.81, a current ratio of 1.02 and a debt-to-equity ratio of 1.15. The stock’s 50-day simple moving average is $10.10 and its two-hundred day simple moving average is $9.68. AdaptHealth Corp. has a twelve month low of $7.11 and a twelve month high of $11.17.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, February 24th. The company reported ($0.76) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($1.10). AdaptHealth had a negative net margin of 2.18% and a positive return on equity of 3.42%. The business had revenue of $846.29 million for the quarter, compared to the consensus estimate of $832.51 million. During the same quarter last year, the business posted $0.34 EPS. The business’s revenue was down 1.2% compared to the same quarter last year. As a group, equities analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current fiscal year.

Key Headlines Impacting AdaptHealth

Here are the key news stories impacting AdaptHealth this week:

• Positive Sentiment: Major shareholder Richard M. Cashin Jr. executed multiple buys over March 10–12 totaling roughly 2.05 million shares (~$19.9M) at about $9.73/share, lifting his stake to ~15.86M shares — a strong insider vote of confidence that likely supported the rally. Investing.com article
• Positive Sentiment: Other filings and coverage show the same insider purchases (disclosed to the SEC) and note a multi-day, material increase in Cashin’s position — reinforcing the market interpretation of the buy as strategic accumulation rather than one-off trading. InsiderTrades article
• Positive Sentiment: Institutional activity shows selective buying (e.g., Goldman Sachs, UBS, new position from Woodline), which can add buying pressure and liquidity support. MarketBeat institutional note
• Neutral Sentiment: Analyst coverage is mixed — several “outperform”/buy ratings and raises to price targets offset by some downgrades and cuts; consensus is a moderate-buy with an average target ~ $13.25, so analyst views provide both support and caution. MarketBeat analyst summary
• Neutral Sentiment: Valuation write-ups are assessing the stock after recent weakness — useful for longer-term context but not an immediate catalyst. Yahoo Finance article
• Neutral Sentiment: Reported short-interest data in recent feeds appears inconsistent (shows 0 shares/NaN increases), so don’t read too much into those numbers until corrected filings are available.
• Negative Sentiment: Recent quarterly results (Feb. 24) included a large EPS miss (reported -$0.76 vs. consensus $0.34) and slight revenue decline year-over-year — fundamental weakness that has pressured valuation and explains earlier share-price weakness. SEC / MarketBeat filing

Institutional Trading of AdaptHealth

A number of hedge funds have recently bought and sold shares of the company. Exchange Traded Concepts LLC bought a new position in AdaptHealth during the third quarter valued at approximately $1,171,000. Prospera Financial Services Inc raised its stake in shares of AdaptHealth by 75.2% during the second quarter. Prospera Financial Services Inc now owns 43,287 shares of the company’s stock worth $408,000 after acquiring an additional 18,586 shares in the last quarter. Bastion Asset Management Inc. bought a new stake in shares of AdaptHealth in the 3rd quarter worth approximately $4,199,000. LSV Asset Management bought a new stake in shares of AdaptHealth in the 2nd quarter worth approximately $448,000. Finally, Bailard Inc. boosted its stake in shares of AdaptHealth by 41.6% in the 2nd quarter. Bailard Inc. now owns 42,058 shares of the company’s stock valued at $397,000 after purchasing an additional 12,358 shares in the last quarter. Institutional investors own 82.67% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on AHCO. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Leerink Partners decreased their price target on shares of AdaptHealth from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, February 26th. Royal Bank Of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a research report on Wednesday, February 25th. Wall Street Zen downgraded shares of AdaptHealth from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Finally, Weiss Ratings lowered shares of AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research report on Wednesday, February 25th. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, AdaptHealth currently has a consensus rating of “Moderate Buy” and a consensus target price of $13.25.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.